Clinical Trials Browser

Phase 1/2 × Colorectal Cancer Metastatic × Oxaliplatin × Clear all

NCT04940546 2024-12-03

Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients

Phase 1/2 Active not recruiting

Gastrointestinal

Colorectal Cancer Metastatic

NCT01955629 2016-04-18

AMOR

Phase 1/2 Terminated

4 enrolled 7 charts

Gastrointestinal

Colorectal Cancer Metastatic